Westlake BioPartners Fund I, L.P.

Filings by Westlake BioPartners Fund I, L.P. span 2 companies, the busiest being Latigo Biotherapeutics, Inc. and Kyverna Therapeutics, Inc. Over a trading history stretching from 12 February 2024 to 10 August 2026, the count stands at 9 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The record was last updated on 11 August 2026 with a transaction in Latigo Biotherapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.